It will take a good fifteen-twenty years, but you simply trick the small nation. Overthrow their government. Propagandize their minds. Steal their elections. Bribe their media. Bribe the teachers. Bribe the musicians.
Bribe the military. Invest billions of dollars in a long-running color revolution.
As USAID documents will reveal, all this started in 2003 as the US State Department persuaded Ukraine they could poke the bear and expect Western backup "to the last man." Which means when it's all over, there will only be one Ukrainian male left alive. No one really thought about that because the slogans all sounded so inspiring.
"The campaign is an American creation, a sophisticated and brilliantly conceived exercise in Western branding and mass marketing," The Guardian's Ian Traynor wrote of the 2004 upheaval in November that year.
How Much Did the "Orange Revolution" Cost?
The US and its allies reportedly spent $65–$100 million over two years to support Viktor Yushchenko-led opposition, with much of the funding allegedly covert and funneled through NGOs.
The US State Department:
in FY2003 and FY2004 officially allocated $188.5 million and $143.47 million, respectively, for "assistance programs" in Ukraine
$54.7 million (FY2003) and $34.11 million (FY2004) went specifically to "democracy programs" in Ukraine on the eve of the 2004 election
"Democracy program" funds were used for electoral and government reform, independent media, political development, and training for administrators, lobbyists, and NGOs. The money was channeled through the US Agency for International Development (USAID), the Eurasia Foundation, National Endowment for Democracy (NED), US Embassy in Kiev, and others.
The FDA has rejected its strongest safety warning for Covid mRNA vaccines despite acknowledging that children were killed by the products.
This news surfaced during a televised Bloomberg interview with FDA Commissioner Marty Makary, who said the agency has “no plans” to apply its strongest safety warning to Covid mRNA vaccines.
In that interview, Makary confirmed that the FDA’s own safety and epidemiology centre had formally recommended a boxed warning — a step reserved, under FDA rules, for drugs with “special problems, particularly ones that may lead to death or serious injury.”